Works matching IS 14741776 AND DT 2009 AND VI 8 AND IP 12
Results: 24
The future of drug development: advancing clinical trial design.
- Published in:
- 2009
- By:
- Publication type:
- review
Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Lessons from 60 years of pharmaceutical innovation.
- Published in:
- 2009
- By:
- Publication type:
- Historical Material
Voltage-gated potassium channels as therapeutic targets.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Pharmaceutical industry financial performance.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 927, doi. 10.1038/nrd3049
- By:
- Publication type:
- Article
Telavancin.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Seven-transmembrane receptors: One way only.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Biologics: The quest for a universal antidote.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Medicinal chemistry: Exploring the third dimension.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Chemoinformatics: Where 'magic bullets' go astray.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Cancer: A Ras and NF-kappaB pas de deux.
- Published in:
- 2009
- By:
- Publication type:
- journal article
In brief.
- Published in:
- 2009
- Publication type:
- Abstract
Robert Stoll.
- Published in:
- 2009
- By:
- Publication type:
- Interview
Deal watch: Alcon licenses complement pathway inhibitor for macular degeneration.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 922, doi. 10.1038/nrd3063
- Publication type:
- Article
Deal watch: Novartis acquires marketing rights for novel broad-spectrum antibiotic.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 922, doi. 10.1038/nrd3064
- Publication type:
- Article
Deal watch: Trends in platform technology deal-making.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 923, doi. 10.1038/nrd3065
- By:
- Publication type:
- Article
Imaging.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 1003, doi. 10.1038/nrd3066
- Publication type:
- Article
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 913, doi. 10.1038/nrd3067
- Publication type:
- Article
Escaping the pincer.
- Published in:
- 2009
- Publication type:
- Editorial
Targeting RNA: an emerging hope for treating muscular dystrophy.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 917, doi. 10.1038/nrd3069
- By:
- Publication type:
- Article
Developing tools for stratified medicine.
- Published in:
- 2009
- By:
- Publication type:
- journal article
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 921, doi. 10.1038/nrd3071
- Publication type:
- Article
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 924, doi. 10.1038/nrd3072
- By:
- Publication type:
- Article